Aarti Drugs Financials
NSE: AARTIDRUGS | BSE: 524348
₹428.50
₹-8.50
(-1.95%)
As on 11-Sep-2026IST
Market cap
₹3,910 Cr
Revenue (TTM)
₹2,678 Cr
P/E Ratio
20.4
P/B Ratio
2.4
Div. Yield
0.5 %
Income Statement (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
2,677.58
|
2,387.03
|
2,528.58
|
2,716.05
|
2,488.65
|
2,154.78
|
|
|
|
|
|
|
Total Income
|
2,680.47
|
2,403.39
|
2,532.61
|
2,718.25
|
2,499.96
|
2,159.30
|
|
|
|
|
|
|
Total Expenditure
|
2,344.26
|
2,096.80
|
2,207.74
|
2,406.60
|
2,156.05
|
1,714.40
|
|
|
|
|
|
|
EBITDA
|
333.32
|
290.23
|
320.83
|
309.45
|
332.60
|
440.38
|
|
|
|
|
|
|
Depreciation
|
70.71
|
55.78
|
51.45
|
50.32
|
50.05
|
49.88
|
|
|
|
|
|
|
EBIT
|
262.61
|
234.45
|
269.39
|
259.13
|
282.55
|
390.49
|
|
|
|
|
|
|
Interest
|
34.37
|
39.04
|
37.89
|
37.14
|
23.91
|
26.23
|
|
|
|
|
|
|
Other Income
|
2.89
|
16.36
|
4.03
|
2.19
|
11.32
|
4.53
|
|
|
|
|
|
|
Exceptional Items
|
-2.09
|
--
|
--
|
--
|
--
|
0.22
|
|
|
|
|
|
|
Profit before Tax
|
229.04
|
211.77
|
235.53
|
224.18
|
269.96
|
369.01
|
|
|
|
|
|
|
Provision for Tax
|
37.94
|
43.67
|
63.94
|
57.82
|
64.96
|
88.62
|
|
|
|
|
|
|
Profit after Tax
|
191.10
|
168.10
|
171.59
|
166.36
|
205.00
|
280.40
|
|
|
|
|
|
|
Minority Interest
|
0.08
|
0.06
|
-0.17
|
-0.05
|
0.04
|
0.01
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
191.18
|
168.16
|
171.42
|
166.31
|
205.04
|
280.41
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,548.86
|
1,369.00
|
1,281.55
|
1,192.43
|
1,036.36
|
913.42
|
|
|
|
|
|
|
Minority Interest
|
0.08
|
0.34
|
0.41
|
0.23
|
-0.06
|
-0.02
|
|
|
|
|
|
|
Non-Current Liabilities
|
343.78
|
368.37
|
354.86
|
279.25
|
231.60
|
257.25
|
|
|
|
|
|
|
Current Liabilities
|
922.26
|
836.97
|
795.54
|
949.48
|
940.06
|
595.36
|
|
|
|
|
|
|
Total Liabilities
|
2,815.26
|
2,574.68
|
2,432.36
|
2,421.40
|
2,207.96
|
1,766.01
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
1,325.82
|
1,236.32
|
1,111.64
|
929.61
|
814.59
|
709.22
|
|
|
|
|
|
|
Current Assets
|
1,467.77
|
1,338.35
|
1,320.72
|
1,491.79
|
1,393.37
|
1,056.80
|
|
|
|
|
|
|
Total Assets
|
2,815.26
|
2,574.68
|
2,432.36
|
2,421.40
|
2,207.96
|
1,766.01
|
|
|
|
|
|
|
Total Debt*
|
--
|
612.24
|
562.42
|
606.52
|
538.34
|
344.38
|
|
|
|
|
|
|
Net Current Assets
|
545.51
|
501.39
|
525.18
|
542.31
|
453.31
|
461.44
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
281.69
|
248.54
|
193.85
|
184.92
|
151.02
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
244.58
|
358.92
|
133.32
|
70.41
|
154.95
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-164.63
|
-223.65
|
-163.97
|
-149.64
|
-71.78
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-82.12
|
-136.03
|
16.54
|
92.03
|
-81.13
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
-2.17
|
-0.76
|
-14.11
|
12.80
|
2.04
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
21.11
|
18.42
|
18.65
|
17.96
|
22.14
|
30.09
|
|
|
|
|
|
|
Cash EPS (₹)
|
20.95
|
24.53
|
24.26
|
23.40
|
27.54
|
35.44
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
175.19
|
149.99
|
139.40
|
128.77
|
111.92
|
98.01
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.47
|
1.00
|
1.00
|
1.00
|
1.00
|
2.50
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
26.80
|
39.04
|
14.40
|
7.60
|
16.63
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
5.51
|
10.82
|
-6.96
|
-9.10
|
6.01
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
13.11
|
15.01
|
15.49
|
20.75
|
34.52
|
|
|
|
|
|
|
ROE (%)
|
12.77
|
12.68
|
13.87
|
14.93
|
21.03
|
35.81
|
|
|
|
|
|
|
ROA (%)
|
7.09
|
6.71
|
7.07
|
7.19
|
10.32
|
16.78
|
|
|
|
|
|
|
EBIT Margin (%)
|
9.81
|
9.82
|
10.65
|
9.54
|
11.35
|
18.12
|
|
|
|
|
|
|
Net Margin (%)
|
7.13
|
6.99
|
6.78
|
6.12
|
8.20
|
12.99
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
9.38
|
8.82
|
7.98
|
10.25
|
15.33
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
10.54
|
-5.60
|
-6.90
|
9.14
|
15.49
|
19.31
|
|
|
|
|
|
|
EBIT Growth (%)
|
9.85
|
-12.97
|
3.96
|
-8.29
|
-27.64
|
80.15
|
|
|
|
|
|
|
Net Profit Growth (%)
|
2.05
|
-2.04
|
3.15
|
-18.85
|
-26.89
|
98.30
|
|
|
|
|
|
|
EPS Growth (%)
|
1.25
|
-1.19
|
3.82
|
-18.89
|
-26.41
|
98.31
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
6.82
|
7.47
|
15.06
|
13.46
|
39.99
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
20.45
|
18.44
|
23.27
|
18.81
|
19.37
|
23.09
|
|
|
|
|
|
|
Price / Book Value
|
2.45
|
2.27
|
3.11
|
2.62
|
3.83
|
7.09
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.47
|
0.29
|
0.23
|
0.30
|
0.23
|
0.36
|
|
|
|
|
|
|
EV/EBITDA
|
13.31
|
12.09
|
13.98
|
11.95
|
13.05
|
15.31
|
|
|
|
|
|
|
Close Price (₹)
|
377.90
|
340.30
|
434.30
|
337.75
|
429.10
|
694.30
|
|
|
|
|
|
|
High Price (₹)
|
574.95
|
635.00
|
645.75
|
531.60
|
841.80
|
1,026.95
|
|
|
|
|
|
|
Low Price (₹)
|
318.60
|
330.05
|
332.05
|
310.80
|
418.50
|
125.00
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
3,909.55
|
3,101.47
|
3,988.58
|
3,128.08
|
3,972.54
|
6,475.54
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.17
|
0.45
|
0.44
|
0.51
|
0.52
|
0.38
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.20
|
0.17
|
0.30
|
0.34
|
0.17
|
|
|
|
|
|
|
Current Ratio
|
1.59
|
1.60
|
1.66
|
1.57
|
1.48
|
1.78
|
|
|
|
|
|
|
Quick Ratio
|
1.06
|
1.03
|
1.05
|
1.03
|
0.92
|
1.08
|
|
|
|
|
|
|
Interest Coverage
|
7.66
|
6.42
|
7.22
|
7.04
|
12.29
|
15.07
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
30.99
|
31.47
|
27.86
|
31.84
|
30.13
|
25.77
|
|
|
|
|
|
|
Asset Turnover
|
0.99
|
0.95
|
1.04
|
1.17
|
1.25
|
1.29
|
|
|
|
|
|
|
Receivable days
|
--
|
111.30
|
113.27
|
108.50
|
95.71
|
88.41
|
|
|
|
|
|
|
Inventory Days
|
--
|
73.31
|
72.33
|
70.03
|
69.00
|
62.71
|
|
|
|
|
|
|
Payable days
|
--
|
104.72
|
102.98
|
95.49
|
90.28
|
95.27
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
79.88
|
82.62
|
83.04
|
74.43
|
55.85
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
